Why does the SimonMed partnership matter for 4DMedical (ASX:4DX)?

SimonMed is one of the largest physician-led radiology practices in the US, operating over 170 outpatient imaging centres across 10 states. Partnering with an influential network gives 4DMedical immediate, large-scale deployment of its next-generation CT-based functional imaging technology.

What is the immediate financial impact of this deal on 4DMedical (ASX:4DX)?

The agreement is not immediately financially material for 4DMedical. However, management notes that it represents a substantial long-term commercial opportunity because pricing is structured on 4DMedical's per-scan rates.

How does this agreement fit into 4DMedical’s long-term business strategy?

The deal utilizes 4DMedical’s scalable Software-as-a-Service (SaaS) delivery model to integrate into SimonMed's existing CT imaging workflow. This demonstrates how the company plans to expand internationally without heavy infrastructure costs.

What are the main bull points for 4DMedical (ASX:4DX) after this news?

The partnership provides immediate validation from a major US healthcare player and generates per-scan commercial revenue from day one. Additionally, accessing SimonMed’s massive network helps build the clinical track record necessary for broader adoption.

Image for illustrative purposes only. Not a real photo.

4DMedical secures US Outpatient expansion contract

Q: What commercial agreement did 4DMedical (ASX:4DX) announce with SimonMed Imaging?

4DMedical secured a three-year contract with SimonMed Imaging to deploy its advanced quantitative cardiopulmonary analysis solutions, CT:VQ and LVAF. SimonMed will roll out these technologies across its entire US network on commercial terms from day one.

Written by Isaac FrancisPublished May. 29 2026Last Updated May. 29 2026

4DMedical (ASX:4DX) has secured a commercial agreement with SimonMed Imaging, marking an expansion of its next-generation CT-based functional imaging technology into the United States outpatient market.

Under the three-year contract, SimonMed will immediately deploy 4DMedical's advanced quantitative cardiopulmonary analysis solutions, CT:VQ and LVAF, across its extensive network on commercial terms.

Headquartered in Scottsdale, Arizona, SimonMed is one of the largest and most influential physician-led radiology practices in the US, operating over 170 outpatient imaging centres across 10 states.

The integration of 4DMedical’s scalable Software-as-a-Service delivery model will complement SimonMed's existing CT imaging services to enhance clinical decision-making for pulmonary assessment.

While the agreement is not immediately financially material, it represents a substantial long-term commercial opportunity for the Melbourne-based company.

A core component of the partnership involves collaborating to support the development of reimbursement evidence for CT:VQ.

SimonMed will share insurance and claims data across its vast network to inform future payor engagement with both public and private providers.

At the time of reporting, 4DMedical’s share price was $3.77.